ANROVSNRSN• 6 Months (Normalized)
ANRO vs NRSN (Alto Neuroscience Inc. vs NeuroSense Therapeutics Ltd.)
Showing Closing Date Range from Apr 3 to Sep 30, 2026.
Normalized cumulative comparison anchored at 0.00% baseline to illustrate pure alpha, return divergence, and market momentum.
ANRO Performance $27.5
+%
Alto Neuroscience Inc.
Normalized Baseline0.00%
NRSN Performance $4.78
+527.3%
NeuroSense Therapeutics Ltd.
Normalized Baseline0.00%
Alpha Spread Margin NRSN LEADS
-527.3 pts
NRSN outperforming by 527.30 percentage points
ANRONRSN
Spread Trajectory6 Months (Normalized)
Cumulative Performance Trajectory
Interactive divergence comparison normalized at 0.00% on start date.
ANRO NRSN
Comparative Historical Ledger
Daily closing prices, normalized percentages, and relative spread divergence.
Historical Quotes & Breakdown(123 dates)
| Date | ANRO Price | ANRO Gain (%) | NRSN Price | NRSN Gain (%) | Spread |
|---|---|---|---|---|---|
| Sep 29, 2026 | $- | $4.78 | +527.30% | - | |
| Sep 28, 2026 | $- | $5.10 | +569.29% | - | |
| Sep 25, 2026 | $- | $6.95 | +812.07% | - | |
| Sep 24, 2026 | $- | $7.40 | +871.13% | - | |
| Sep 23, 2026 | $27.50 | +22.06% | $7.40 | +871.13% | -849.07% |
| Sep 22, 2026 | $30.78 | +36.62% | $7.18 | +842.26% | -805.64% |
| Sep 21, 2026 | $30.63 | +35.95% | $6.62 | +768.77% | -732.82% |
| Sep 18, 2026 | $30.27 | +34.35% | $6.35 | +733.33% | -698.98% |
| Sep 17, 2026 | $30.98 | +37.51% | $6.72 | +781.89% | -744.38% |
| Sep 16, 2026 | $30.00 | +33.16% | $6.49 | +751.71% | -718.55% |
| Sep 15, 2026 | $30.25 | +34.27% | $7.03 | +822.57% | -788.30% |
| Sep 14, 2026 | $31.68 | +40.61% | $6.90 | +805.51% | -764.90% |
| Sep 11, 2026 | $32.00 | +42.03% | $0.35 | -54.46% | +96.49% |
| Sep 10, 2026 | $31.68 | +40.61% | $0.33 | -56.43% | +97.04% |
| Sep 09, 2026 | $34.07 | +51.22% | $0.40 | -47.38% | +98.60% |
Page 1 of 9